What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Major depressive disorder
- Psychiatry
Philip J. Cowen mainly focuses on Internal medicine, Endocrinology, Serotonin, Antidepressant and Psychiatry.
His research integrates issues of Tyrosine, Phenylalanine, Major depressive disorder, Depression and Positron emission tomography in his study of Internal medicine.
His studies deal with areas such as Agonist and Receptor as well as Endocrinology.
Philip J. Cowen interconnects Tryptophan, Neuroscience and Crossover study in the investigation of issues within Serotonin.
His biological study spans a wide range of topics, including Clinical psychology and Mood.
The concepts of his Prolactin study are interwoven with issues in Appetite, Anorectic and Pharmacology.
His most cited work include:
- Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment (565 citations)
- Direct radioimmunoassay for melatonin in plasma. (551 citations)
- Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. (430 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Endocrinology, Depression, Pharmacology and Antidepressant are his primary areas of study.
Internal medicine is often connected to Placebo in his work.
His work carried out in the field of Endocrinology brings together such families of science as Tryptophan and Agonist, Receptor.
Depression is the subject of his research, which falls under Psychiatry.
His research in Pharmacology intersects with topics in Antagonist and Pindolol.
Philip J. Cowen has included themes like Randomized controlled trial and Clinical psychology, Mood in his Antidepressant study.
He most often published in these fields:
- Internal medicine (45.53%)
- Endocrinology (39.40%)
- Depression (20.49%)
What were the highlights of his more recent work (between 2013-2021)?
- Depression (20.49%)
- Antidepressant (20.14%)
- Psychiatry (17.86%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Depression, Antidepressant, Psychiatry, Internal medicine and Neuroscience.
His Depression research includes themes of Inflammation, Glutamate receptor, Emotional processing and Serotonin.
His Antidepressant research is multidisciplinary, relying on both Receptor, Placebo, Cognition and Clinical psychology.
His work on Traumatic stress, Post-traumatic stress disorder, MDMA and Schizophrenia as part of general Psychiatry study is frequently linked to Service personnel, bridging the gap between disciplines.
His work deals with themes such as Escitalopram and Endocrinology, which intersect with Internal medicine.
His studies in Endocrinology integrate themes in fields like Glutamine and Glutamic acid.
Between 2013 and 2021, his most popular works were:
- Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines (305 citations)
- Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers (217 citations)
- How do antidepressants work? New perspectives for refining future treatment approaches (173 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Major depressive disorder
- Psychiatry
His primary areas of investigation include Psychiatry, Internal medicine, Neuroscience, Antidepressant and Depression.
Philip J. Cowen focuses mostly in the field of Psychiatry, narrowing it down to topics relating to Audiology and, in certain cases, Transcranial direct-current stimulation, Stimulation and Dorsolateral prefrontal cortex.
Philip J. Cowen regularly ties together related areas like Endocrinology in his Internal medicine studies.
The Neuroscience study combines topics in areas such as Nuclear magnetic resonance spectroscopy and Inositol.
He combines subjects such as Biomarker, Drug action, Randomized controlled trial and Clinical onset with his study of Antidepressant.
His Depression research is multidisciplinary, incorporating elements of Hippocampus and Immune system.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
